Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.

@article{Dengler2010EarlyTW,
  title={Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.},
  author={Reinhard Dengler and Hans-Christoph Diener and Andreas Schwartz and Martin Grond and Helmut Schumacher and Thomas Machnig and Christoph Cyrill Eschenfelder and Joachim Leonard and Karin Weissenborn and Andreas Kastrup and Roman Ludwig Haberl},
  journal={The Lancet. Neurology},
  year={2010},
  volume={9 2},
  pages={159-66}
}
BACKGROUND Little is known about the best antiplatelet treatment immediately after ischaemic stroke or transient ischaemic attack (TIA). The EARLY trial aimed to compare outcome in patients given aspirin plus extended-release dipyridamole twice daily either within 24 h of stroke or TIA or after 7 days of aspirin monotherapy. METHODS In 46 stroke units in… CONTINUE READING